Modifiers of the oligomycin sensitivity of the mitochondrial F1F0-ATPase

Mitochondrion

Volumn 13, Issue 4, 2013, Pages 312-319

  Pagliarani, Alessandra ^a   Nesci, Salvatore ^a   Ventrella, Vittoria ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

F1F0 ATPase; Inhibition mechanism; Mitochondria; Oligomycin

Indexed keywords

ANTIBIOTIC AGENT; APOPTOLIDIN; BAFILOMYCIN; BENZODIAZEPINE DERIVATIVE; CONCANAMYCIN A; CYTOVARICIN; OLIGOMYCIN; ORGANIC SOLVENT; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRIBUTYLTIN; UNCLASSIFIED DRUG;

AGING; ALCOHOLISM; ANTIBIOTIC SENSITIVITY; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DETERMINATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; FASCIOLIASIS; MOLECULAR DYNAMICS; NEUROMUSCULAR DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; ENZYME INHIBITORS; MITOCHONDRIAL DISEASES; OLIGOMYCINS; PROTON-TRANSLOCATING ATPASES;

EID: 84877342082     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2013.04.005     Document Type: Review

References (79)

1. 1 ATP synthase of streptomycetes: modulation of activity and oligomycin resistance by protein Ser/Thr kinases. Biochemistry 2009, 3:16-23.
2. Barogi S., Baracca A., Parenti Castelli G., Bovina C., Formiggini G., Marchetti M., Solaini G., Lenaz G. Lack of major changes in ATPase activity in mitochondria from liver, heart, and skeletal muscle of rats upon ageing. Mech. Ageing Dev. 1995, 84:139-150.
3. Berdanier C.D. Linking mitochondrial function to diabetes mellitus: an animal's tale. Am. J. Physiol. 2007, 293:C830-C836.
4. Bertina R.M., Steenstra J.A., Slater E.C. The mechanism of inhibition by oligomycin of oxidative phosphorylation in mitochondria. Biochim. Biophys. Acta 1974, 368:279-297.
5. Boyer P.D. The ATP synthase-a splendid molecular machine. Annu. Rev. Biochem. 1997, 66:717-749.
6. Breen G.A., Miller D.L., Holmans P.L., Welch G. Mitochondrial DNA of two independent oligomycin-resistant Chinese hamster ovary cells contains a single nucleotide change in the ATPase 6 gene. J. Biol. Chem. 1986, 261:11680-11685.
7. Bronnikov G.E., Vinogradova S.O., Mezentseva V.S. Changes in kinetics of ATP synthetase and in concentrations of adenine nucleotides in ground squirrel liver mitochondria during hibernation. Comp. Biochem. Physiol. 1990, 97B:411-415.
8. Bruni A., Van Dijck P.W.M., De Gier J. The role of phospholipid acyl chains in the activation of mitochondrial complex. Biochim. Biophys. Acta 1975, 406:315-328.
9. Cortés A., Cascante M., Càrdenas M.L., Cornish-Bowden A. Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochim. J. 2001, 357:263-268.
10. 0-synthase without preventing enzyme assembling and oligomerization. J. Biol. Chem. 2007, 282:1051-1058.
11. Dassa E.P., Paupe V., Gonçalves S., Rustin P. The mtDNA NARP mutation activates the actin-Nrf2 signaling of antioxidant defences. Biochem. Biophys. Res. Commun. 2008, 368:620-624.
12. Degli Esposti M., Bertoli E., Parenti-Castelli G., Lenaz G. Interactions between ubiquinone and ATPase in mitochondrial membranes. J. Bioenerg. Biomembr. 1981, 23:37-50.
13. Devenish R.J., Prescott M., Boyle G.M., Nagley P. The oligomycin axis of mitochondrial ATP synthase: OSCP and the proton channel. J. Bioenerg. Biomembr. 2000, 32:507-514.
14. Dorward A.M., Singh G. Energetic characteristic of cisplatin resistant ovarian carcinoma cells. Anticancer. Res. 1996, 16:443-447.
15. Drose S., Altendorf K. Bafilomycin and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 1997, 200:1-8.
16. Edwards S.W., Evans J.B., Lloyd D. The mitochondrial adenosine triphosphatase of Acanthamoeba castellanii. Partial characterization and changes in the activity during exponential growth. Comp. Biochem. Physiol. 1982, 71B:495-500.
17. Farrell L.B., Gearing D.P., Nagley P. Reprogrammed expression of subunit 9 of the mitochondrial ATPase complex of Saccharomyces cerevisiae. Expression in vitro from a chemically synthesized gene and import into isolated mitochondria. Eur. J. Biochem. 1988, 173:131-137.
18. Felty Q., Roy D. Estrogen, mitochondria and growth of cancer and non-cancer cells. J. Carcinogenesis 2005, 4:1. (http://www.carcinogenesis.com/content 4/1/1). 10.1186/1477-3163-4-1.
19. Fernandez-Checa J.C., Hirano T., Tsukamoto H., Kaplowitz N. Mitochondrial glutathione depletion in alcoholic liver disease. Alcohol 1993, 10:469-475.
20. Fiorini R., Pagliarani A., Nesci S., Pirini M., Tucci E., Ventrella V. Structural and functional changes in gill mitochondrial membranes from the Mediterranean mussel Mytilus galloprovincialis exposed tri-n-butyltin. Environ. Toxicol. Chem. 2012, 31:877-884.
21. +-ATPase. Curr. Med. Chem. 1999, 6:1197-1212.
22. Glaser E., Norling B., Kopeki J., Ernster L. Comparison of the effects of oligomycin and dicyclohexylcarbodiimide on mitochondrial ATPase and related reactions. Eur. J. Biochem. 1986, 121:525-531.
23. Green R.C., Thumser A.E., Povey D., Saldanha J.W., Potter B.S., Palmer R.A., Howling B.J. A comparative study of the single crystal X-ray determination and molecular modelling of the binding of oligomycin to ATP synthase. Comput. Biol. Chem. 2009, 33:189-195.
24. O-ATP synthase is disrupted upon interference of RNA editing in Trypanosoma brucei. Int. J. Parasitol. 2010, 40:45-54.
25. Hong S., Petersen P.L. ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease and other scientific areas. Microbiol. Mol. Biol. Rev. 2008, 72:590-641.
26. Houštěk J., Pìckovà A., Vojtìškpvá Mrácek T., Pecina P., Ješina P. Mitochondrial diseases and genetic defects of ATP synthase. Biochim. Biophys. Acta 2006, 1757:1400-1405.
27. 1-ATPase activity. Fish Physiol. Biochem. 2003, 29:237-244.
28. 0-ATP synthase: modulation of the body's powerhouse and its implications for human disease. Curr. Med. Chem. 2011, 18:4684-4714.
29. Jonckeere A.L., Speitink J.A.M., Rodenburg R.J.T. Mitochondrial ATP synthase. Architecture, function and pathology. J. Inherit. Metab. Dis. 2012, 35:211-225.
30. Joshi S., Cao G.J., Nath C., Shah J. Oligomycin sensitivity conferring protein (OSCP) of bovine heart mitochondrial ATP synthase: high affinity OSCP-FO interaction requires a local alpha-helix at the C-terminal end of the subunit. Biochemistry 1997, 36:10936-10943.
31. 0-ATPase in diabetes-prone BHE/CdB rats with respect to Sprague-Dawley rats. Am. J. Physiol. 1999, 77:E702-E707.
32. Kucharczyk R., Rak M., di Rago P. Biochemical consequences in yeast of the human mitochondrial DNA 8993T>C mutation in the ATPas6 gene found in NARP/MILS patients. Biochim. Biophys. Acta 2009, 1793:817-824.
33. Kucharczyk R., Salin B., di Rago J.P. Introducing the human Leigh syndrome mutation T9176G into Saccharomyces cerevisiae mitochondrial DNA leads to severe defects in the incorporation of Atp6p into the ATP synthase and in the mitochondrial pathology. Hum. Mol. Gen. 2009, 18:2889-2898.
34. Kucharczyk R., Ezkurdia N., Couplan E., Procaccio V., Ackerman S.H., Blondel M., di Rago J.P. Consequences of the pathogenic T9176C mutation of human mitochondrial DNA on yeast mitochondrial ATP synthase. Biochim. Biophys. Acta 2010, 1797:1105-1112.
35. Kuhns M.C., Eisenstadt J.M. Oligomycin-resistant mitochondrial ATPase from mouse fibroblasts. Somat. Cell Mol. Genet. 1979, 5:821-832.
36. Lenaz G., Curatola G., Mazzanti L., Parenti-Castelli G. Biophysical studies on agents affecting the state of membrane lipids: biochemical and pharmacological implications. Mol. Cell. Biochem. 1978, 22:3-32.
37. Lenaz G., Curatola G., Mazzanti L., Parenti-Castelli G., Landi L., Sechi A.M. A conformational model of the action of general anesthetics at the membrane level. III. Anesthetics and the properties of membrane-bound enzymes: mitochondrial ATPase. Int. J. Biochem. 1978, 27:431-449.
38. 0-ATPase in mitochondria from rats infected with the liver fluke Fasciola hepatica. Biochim. Biophys. Acta 1994, 1186:237-242.
39. Lenton L.M., Bygrave F.L., Behm C.A. Fasciola hepatica infection in sheep: changes in liver metabolism. Res. Vet. Sci. 1996, 61:152-156.
40. Levy H.M., Sharon N., Ryan E.M., Koshland D.E. Effect of temperature on the rate of hydrolysis of adenine triphosphate and inosine triphosphate by myosin with and without modifiers. Biochim. Biophys. Acta 1962, 56:118-126.
41. Manfredi G., Gupta N., Vasquez M.E., Sadlock J.E., Spinazzola A., DeVivo D.C., Schon E.A. Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene. J. Biol. Chem. 1999, 274:9331-9386.
42. Mattiazzi M., Vijayvergiya C., Gayewski C.D., DeVivo D.C., Lenaz G., Wiedmann M., Manfredi G. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum. Mol. Gen. 2004, 13:869-879.
43. Mitome N., Ono S., Sato H., Suzuki T., Sone T., Yoshida M. Essential arginine residue of the F(O)-a subunit in F(O)F(1)-ATP synthase has a role to prevent the proton shortcut without c-ring rotation in the F(O) channel. Biochem. J. 2010, 430:171-177.
44. 1 ATPase. J. Biol. Chem. 1987, 262:13285-13289.
45. Nadanaciva S., Bernal A., Aggeler R., Capaldi R., Will Y. Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. Toxicol. in Vitro 2007, 21:902-911.
46. Nesci S., Ventrella V., Trombetti F., Pirini M., Borgatti A.R., Pagliarani A. Tributyltin (TBT) and dibutyltin (DBT) differently inhibit the mitochondrial Mg-ATPase activity in mussel digestive gland. Toxicol. in Vitro 2011, 25:117-124.
47. 1-ATPase sensitivity to oligomycin in mussel mitochondria. Appl. Organomet. Chem. 2012, 26:593-599.
48. 0-ATPase function by butyltin compounds. Appl. Organomet. Chem. 2013, 27:199-205.
49. Nesci S., Ventrella V., Trombetti F., Pirini M., Pagliarani A. Mussel and mammalian ATP synthase share the same bioenergetic cost of ATP. J. Bioenerg. Biomembr. 2013, (in press). 10.1007/s10863-013-9504-1.
50. Opperdoes F.R., Bost P., De Ruke D. Oligomycin sensitivity of the mitochondrial ATPase as a marker for fly transmissability and the presence of functional kinetoplast DNA in African trypanosomes. Comp. Biochem. Physiol. B 1976, 55(1):25-30.
51. Palmer R.A., Potter B.S. X-ray structures and absolute configurations of the antibiotics oligomycins A, B and C: inhibitors of ATP synthase. J. Chromatogr. Crystallogr. 2008, 38:243-253.
52. Petros J.A., Baumann A.K., Ruiz-Pesini E., Amin M.B., Sun C.Q., Hall J., Lim S., Issa M.M., Flanders W.D., Hosseini S.H., Marshall F.F., Wallace D.C. mtDNA mutations increase tumorigenicity in prostate cancer. PNAS 2005, 102:719-724.
53. Przybylski P., Brezinski B., Bartls F. Oligomycin A complex structures with some divalent metal cations studied by ESI, MS and PM5 semiempirical methods. J. Mol. Struct. 2007, 830:58-71.
54. Ramirez F., Marecek J.F., Tu S., Kantor T.V., Okazaki H. Effects of borohydride-treated oligomycins on processes of energy transduction in mitochondria. Eur. J. Biochem. 1982, 121:275-279.
55. Rigoulet M., Devin A., Averet N., Vandois B., Guerin B. Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol. Eur. J. Biochem. 1996, 241:280-285.
56. Rule C.J., Behm C.A., Bygrave F.L. Aberrant energy-linked reactions in mitochondria isolated from the livers of rats infected with the liver fluke Fasciola hepatica. Biochem. J. 1989, 260:517-523.
57. 1-ATPase. PNAS 2000, 97:14766-14771.
58. Salomon A.R., Zhang Y., Seto H., Khosta C. Structure-activity relationships within a family of selectively cytotoxic macrolide natural products. Org. Lett. 2001, 3:57-59.
59. Sgarbi G., Baracca A., Lenaz G., Valentino L.M., Carelli V., Solaini G. Inefficient coupling between proton transport and ATP synthesis may be the pathogenic mechanism for NARP and Leigh syndrome resulting from T899 mutation in mtDNA. Biochem. J. 2006, 395:493-500.
60. Shidara Y., Yamagata K., Kanamori T., Nakano K., Kwong J.Q., Manfredi G., Oda H., Ohta S. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 2005, 65:1655-1663.
61. Slott E.F., Shade R.O., Lansman R.A. Sequence analysis of mitochondrial DNA in a mouse cell line resistant to cloramphenicol and oligomycin. Mol. Cell. Biol. 1983, 3:1694-1702.
62. Smith R.M., Peterson W.H., Mccoy E. Oligomycin, a new antifungal antibiotic. Antibiot. Chemother. 1954, 4:962-970.
63. Snoeij N.J., Penninks A.H., Seinen W. Biological activity of organotin compounds-an overview. Env. Res. 1987, 44:335-363.
64. Solaini G., Harris D.A., Lenaz G., Sgarbi G., Baracca A. The study of pathogenic mechanism of mitochondrial diseases provides information on basic bioenergetics. Biochim. Biophys. Acta 2008, 1777:941-945.
65. Soper J.W., Petersen P.L. Adenosine triphosphatase of rat liver mitochondria: detergent solubilization of an oligomycin- and dicyclohexylcarbodiimide-sensitive form of the enzyme. Biochemistry 1976, 15:2682-2690.
66. 0-ATPase. Biopolymers 2010, 93:85-92.
67. Symersky J., Osowski D., Walters D.E., Mueller D.M. Oligomycin frames a common drug-binding site in the ATP synthase. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:13961-13965.
68. Teplova V.V., Tohshin A.A., Grigoriev P.A., Saris N.E., Salkinoja-Salonen M.S. Bafilomycin A1 is a potassium ionophore that impairs mitochondrial functions. J. Bioenerg. Biomembr. 2007, 39:321-329.
69. Tyler D.D., Webb P. Puridfication and properties of the adenosine triphosphatase released from the liver mitochondrial membrane by chloroform. Biochem. J. 1979, 178:289-297.
70. Tzagoloff A. Assembly of the mitochondrial membrane system. III. Function and synthesis of the oligomycin sensitivity conferring protein of yeast mitochondria. J. Biol. Chem. 1970, 245:1545-1551.
71. Vazquez-Memije M.E., Shanske S., Santorelli F.M., Kranz-Eble P., DeVivo D.C., DiMauro S. Comparative biochemical studies of ATPases in cells from patients with the T8993G or T8993C mitochondrial DNA mutations. J. Inherit. Metab. Dis. 1998, 21:829-836.
72. Venditti P., Di Stefano L., Di Meo S. Mitochondrial metabolism of reactive oxygen species. Mitochondrion 2013, 13:71-82.
73. Ventrella V., Nesci S., Trombetti F., Bandiera P., Pirini M., Borgatti A.R., Pagliarani A. Tributyltin inhibits the oligomycin-sensitive Mg-ATPase activity in Mytilus galloprovincialis digestive gland mitochondria. Comp. Biochem. Physiol. C 2011, 153:75-81.
74. von Ballmoos C., Cook G.M., Dimroth P. Unique rotary ATP synthase and its biological diversity. Annu. Rev. Biophys. 2008, 37:43-64.
75. 1-ATPase. Circulation 1995, 91:2810-2818.
76. Walker J. The ATP synthase: the understood, the uncertain and the unknown. Biochem. Soc. Trans. 2013, 41:1-16.
77. Watt I.N., Montgomery M.G., Runswick M.J., Leslie A.G., Walker J.E. Bioenergetic cost of making an adenosine triphosphate molecule in animal mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16823-16827.
78. 1-ATP synthase/ATPase. J. Steroid Biochem. Mol. Biol. 1999, 68:66-75.
79. +-ATPase of porcine cortex. Eur. J. Pharmacol. 1999, 368:95-102.